Correlation between the serum FABP4, ANGPTL3, and ANGPTL4 levels and coronary artery disease
Clinical Cardiology · 2024
DOI: 10.1002/clc.24246 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Cardiology, 2024. Verfasst von Zhuoyan Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Affiliated Hospital of Chengde Medical University, Chengde, China. Hauptthemen laut MEDLINE: Coronary Artery Disease, Hypertension. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Government Funded Clinical Medicine Talent Training Project.
Abstract (Originalsprache)
Background
Lipid metabolism related factors, such as angiopoietin‐like protein 3 (ANGPTL3), angiopoietin‐like 4 (ANGPTL4), fatty acid‐binding protein 4 (FABP4) are newly discovered factors that can affect coronary artery disease (CAD). In this study, we aimed to investigate the relationship between CAD and these lipid metabolism factors. Hypothesis ANGPTL3, ANGPTL4, and FABP4 may provide a new method for the control of CAD risk factors and the prevention and treatment of CAD.
Methods
We enrolled 284 consecutive inpatients with suspected CAD and divided them into CAD and non‐CAD groups based on the coronary angiography results. Serum ANGPTL3, ANGPTL4, FABP4, and tumor necrosis factor‐α (TNF‐α) levels were estimated using the enzyme‐linked immunosorbent assay. Multivariate logistic regression was used to assess the risk factors for CAD. The receiver operating characteristic curve was used to determine the cutoff and diagnostic values.
Results
The serum TNF‐α, FABP4, ANGPTL3, and ANGPTL4 values showed a significant difference between the CAD and non‐CAD groups ( p < .05). After adjusting for confounding factors, the FABP4, ANGPTL3, and ANGPTL4 levels were independently associated with CAD ( p < .05). The ANGPTL3 expression level was an independent risk factor for CAD in patients with hypertension, but not in those without hypertension. The ANGPTL3 > 67.53 ng/mL, ANGPTL4 > 29.95 ng/mL, and FABP4 > 1421.25 ng/L combination had the highest diagnostic value for CAD.
Conclusion
ANGPTL3, ANGPTL4, and FABP4 were identified as independent risk factors for CAD and have valuable clinical implications for the diagnosis and treatment of CAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The Affiliated Hospital of Chengde Medical University, Chengde, China.
- Hebei Key Laboratory of Panvascular Diseases, Chengde, China.
Förderung
- Government Funded Clinical Medicine Talent Training Project
Zitieren
APA
Zhao, Z., Fu, Y., Lian, H., Liu, Y., Liu, J., Sun, L., & Zhang, Y. (2024). Correlation between the serum FABP4, ANGPTL3, and ANGPTL4 levels and coronary artery disease. Clinical Cardiology. https://doi.org/10.1002/clc.24246
Vancouver
Zhao Z, Fu Y, Lian H, Liu Y, Liu J, Sun L, et al. Correlation between the serum FABP4, ANGPTL3, and ANGPTL4 levels and coronary artery disease. Clinical Cardiology. 2024. doi:10.1002/clc.24246
BibTeX
@article{Zhao2024,
author = {Zhao, Zhuoyan and Fu, Ying and Lian, Huan and Liu, Yixiang and Liu, Jingyi and Sun, Lixian and Zhang, Ying},
title = {Correlation between the serum FABP4, ANGPTL3, and ANGPTL4 levels and coronary artery disease},
journal = {Clinical Cardiology},
year = {2024},
doi = {10.1002/clc.24246}
}
EUVIMED